BIOLINE RX earnings per share and revenue

BLRX earnings per share for the last quarter are -0.01 ILS whereas the estimation was -0.00 ILS which accounts for -98.14% surprise. Company revenue for the same period amounts to 42.81 M ILS despite the estimated figure of 28.12 M ILS. Estimated earnings per share for the next quarter are -0.01 ILS, and revenue is expected to reach 5.52 M ILS. Also watch annual changes over time to get a bigger picture of BLRX earnings per share and revenue dynamics.